Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) has cleared its final regulatory hurdle, with full MHRA approval secured for its TOPICAL trial across six UK sites. Interim data on its CRS therapy is expected this summer, with US payer research pointing to a big opportunity. Watch more
Arecor Therapeutics PLC (AIM:AREC) is advancing its lead insulin candidate AT278, which it says outperforms best-in-class rivals for use in insulin pumps. A Phase 2 trial is targeted for the second half of 2026, backed by a partnership with Sequel Med Tech. Watch more
hVIVO PLC (AIM:HVO) beat EBITDA guidance in 2025 and closed the year with over £14 million in cash. The company is guiding for high single-digit revenue growth in 2026, supported by a growing pipeline. Watch more
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) is integrating its Goliath solid-state battery into Brompton's iconic folding e-bike. On-bike trials are expected in 2027, with safety and weight advantages opening doors in markets including China. Watch more
Kodal Minerals PLC (AIM:KOD) had a record March at its Bougouni Lithium Project, shipping over 10,900 tonnes of concentrate. Revenues have topped $51 million since exports began, with a Phase Two flotation plant adding to the project's future potential. Watch more
Connecting Excellence Group Plc (AQSE:XCE, OTCQB:XCELF) says it's the first UK-listed recruiter to invoice and settle fees in Bitcoin. The company is building a dual flywheel model, growing both its recruitment revenues and its Bitcoin treasury simultaneously. Watch more
Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.